Navigation Links
Latin American Peripheral Vascular Device Market Will Expand Strongly To reach Revenues of $335 Million in 2022

TORONTO, Nov. 12, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the Latin American peripheral vascular (PV) device market will grow strongly through 2022. The rapidly expanding economies in the Latin American countries, mirrored by investment in health care, and coupled with increasing disease prevalence, are boosting both the accessibility of health care as well as the patient pool in the region. These factors will spur market growth at about eight percent annually through 2022.


The drug-coated balloon (DCB) market represents an area of fast growth within the PV space. These products have gained popularity because they offer advantages over stenting or PV bypass, particularly in the lower extremities. They are also seen as a cost-saving measure; DCBs are less likely to require bail-out stenting of the vessel compared to standard balloons, and this results in overall lower procedure costs for facilities. DCB uptake will be particularly favorable in Argentina, where physicians are keen adopters of new technology, and in Colombia, where the lower cost of these products relative to other countries will spur faster acceptance. Penetration of these products will be slower in Brazil, where their cost is much closer to a stent and significantly higher than a standard balloon. In Mexico, DCB use will be hindered by the fact that many procedures are paid for out-of-pocket, and in those cases, patients will tend to opt for the lowest-cost procedures.

"The Latin American PV device market will be limited by strong competition from low-cost local manufacturers," said MRG Analyst Roald Dhoska. "The presence of value players will be particularly notable in the synthetic surgical graft and aortic stent graft markets in Brazil. While multinational companies will continue to dominate the private sector, low-cost domestic manufacturers such as Industrias Barone, Braile Biomedica and NANO have had considerable success in the public sector."

Millennium Research Group's Latin American Markets for Peripheral Vascular Devices 2014 report includes unit, procedure, average selling price and revenue information, along with market drivers and limiters and a competitive landscape for PV stents, percutaneous transluminal angioplasty (PTA) balloon catheters, embolic protection devices, inferior vena cava filters (IVCFs), aortic stent grafts, synthetic surgical grafts and PV accessory devices in Argentina, Brazil, Colombia and Mexico. Supplemental country coverage is also available for Chile, Peru and Venezuela, as well as in aggregate for the rest of the Latin American countries.

About Millennium Research Group
Millennium Research Group (, a Decision Resources Group company (, is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Christopher Comfort
Decision Resources Group

Alex Jablokow
Millennium Research Group

SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Palatin Technologies Announces Issuance of Two Natriuretic Peptide Receptor-Specific Mimetic Patents
2. Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on November 14, 2013
3. Stage at Breast Cancer Diagnosis Will Shift Dramatically Over the Next 20 Years in Key Latin American Markets
4. Merrimack Pharmaceuticals Announces Results From A Phase 2 Study Of MM-121 (SAR256212) In Combination With Paclitaxel In Patients With Platinum-Resistant Or Refractory Advanced Ovarian Cancers
5. Palatin Technologies Reports Successful Completion Of Device Bioequivalence Trial
6. University of Miami Program To Train Health Care Executives on Tackling Ethical and Compliance Issues When Doing Business in Latin America
7. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2013 Results
8. Palatin Technologies, Inc. To Report Fiscal Year 2013 Fourth Quarter Results
9. ViSalus, Inc. Sets Sights on Aggressive Growth in Latino Market
10. Aethlon Medical to Present at Exosomes and Circulating Biomarkers 2013 Summit
11. North American and Latin American Economic Outlook: Gaining Traction or Losing Ground?
Post Your Comments:
(Date:6/26/2016)... Story Highlights: ... the health care industry is causing providers to review ... Deloitte offers a suite of solutions for health care ... cost optimization: labor resource analysis, revenue cycle optimization and ... outcomes and better economics ...
(Date:6/24/2016)... 2016  Collagen Matrix, Inc., ("Collagen Matrix") the ... of collagen and mineral based medical devices for ... Bill Messer has joined the company as ... the growing portfolio of oral surgery, neurosurgery, orthopaedic ... joins the Collagen Matrix executive team as an ...
(Date:6/24/2016)... 2016   Bay Area Lyme Foundation , ... Center for Tick Borne Illness , Harvard Medical ... Hacking Medicine, University of California, Berkeley, and the ... five finalists of Lyme Innovation , the ... 100 scientists, clinicians, researchers, entrepreneurs, and investors from ...
Breaking Medicine Technology:
(Date:6/26/2016)... Cary, North Carolina (PRWEB) , ... June 26, 2016 , ... ... the release of a new product that was developed to enhance the health of ... harvested for centuries. , The two main herbs in the PawPaws Cat Kidney ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
Breaking Medicine News(10 mins):